New analysis finds stark difference in coverage of breast cancer medicines for seniors in the United States and England

In the United States, seniors and people with disabilities enjoy broad coverage of physician-administered medicines under Medicare Part B because the program relies on market competition to balance access, innovation and cost control. But the same cannot be said for patients in other countries. In fact, a new analysis from Avalere underscores the dangers of theMost Favored Nation (MFN) rule and other foreign reference pricing proposals.
Source: The Catalyst - Category: Pharmaceuticals Tags: Medicare Part B CMMI International Reference Pricing Source Type: news